Expression of Interferon-Α and Interleukin 8 in Peripheral Blood Mononuclear Cells in Patients with Chronic Hepatitis B

LU Yin-ping,DONG Ji-hua,LIU Zhao,GUAN Shi-he,LIN Yu-lin,YANG Dong-liang
DOI: https://doi.org/10.3969/j.issn.1000-8861.2006.06.015
2006-01-01
Abstract:Objective To detect expression of interferon-α(IFN-α) and interleukin 8 (IL-8) in peripheral blood mononuclear cells (PBMCs) of patients with chronic hepatitis B, and analysis cellular immune status of patients with chronic Hepatitis B virus (HBV) infection. Methods PBMCs of chronic HBV infection patients were cultured. Viral protection assay was used to detect antiviral biological activity of culture supernate from PBMC stimulated with high concentration of PolyIC. IL-8 mRNA from PBMC of patients with chronic hepatitis B was measured by reverse transcription-polymerase chain reaction (RT-PCR). Results For responders (n=13), the activity of IFN-α from PolyIC-stimulated PBMC was enhanced after treated with IFN-α2b, however, non-responders (n=27) continuously kept lower activity of IFN-α from PBMC during IFN-α2b therapy. The expression of IL-8 mRNA in PBMC of responder and non-responder were significantly higher than that of normal control group (n=20) before IFN-α2b therapy (P0.01). After treatment of IFN-α2b, the IL-8 level of responder decreased and level of IL-8 of non-responder kept high. Conclusion The cellular immune function of patients with chronic HBV is impaired. The expression of IFN-α gene of the non-responders of chronic HBV infected patients was inhibited. The level of IL-8 consists with liver inflammation. The IFN-α activity of PBMC perhaps can be a marker for hepatitis B prognosis after IFN- α therapy.
What problem does this paper attempt to address?